CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in RCUS — Arcus Biosciences, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in RCUS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$29,034,337
+$9,515,757 QoQ
Shares Held
941,756
+4.2% QoQ
Ownership
0.740%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 230 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. RCUS ranks #50 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in RCUS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,034,337 | 941,756 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $19,518,580 | 903,638 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $23,073,183 | 968,241 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $11,847,640 | 871,150 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $6,322,679 | 776,742 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $5,604,915 | 714,002 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $8,630,586 | 579,623 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $8,669,108 | 566,979 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $7,728,356 | 507,443 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $9,313,050 | 493,276 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $9,018,676 | 472,182 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $8,272,095 | 460,841 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $8,870,209 | 436,741 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $7,691,643 | 421,691 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $8,038,729 | 388,720 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $9,917,099 | 379,094 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,698,740 | 343,281 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $10,435,345 | 330,651 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $13,037,410 | 322,150 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $12,387,253 | 355,241 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $9,461,590 | 344,559 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $9,358,249 | 333,271 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $7,452,596 | 287,080 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,850,157 | 282,973 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $6,339,699 | 256,253 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $2,723,825 | 196,241 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||